Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,264 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Publisher Correction: Clinical characteristics and immune profile alterations in vaccinated individuals with breakthrough Delta SARS-CoV-2 infections.
Fan Q, Shi J, Yang Y, Tang G, Jiang M, Li J, Tang J, Li L, Wen X, Zhang L, Deng X, Wang Y, Lan Y, Li L, Peng P, Tong Y, Lu H, Yan L, Liu Y, Cai S, Li Y, Mo X, Li M, Deng X, Hu Z, Yu H, Hu F, Liu J, Tang X, Li F. Fan Q, et al. Among authors: peng p. Nat Commun. 2022 Sep 6;13(1):5245. doi: 10.1038/s41467-022-32734-x. Nat Commun. 2022. PMID: 36068226 Free PMC article. No abstract available.
Clinical characteristics and immune profile alterations in vaccinated individuals with breakthrough Delta SARS-CoV-2 infections.
Fan Q, Shi J, Yang Y, Tang G, Jiang M, Li J, Tang J, Li L, Wen X, Zhang L, Deng X, Wang Y, Lan Y, Li L, Peng P, Tong Y, Lu H, Yan L, Liu Y, Cai S, Li Y, Mo X, Li M, Deng X, Hu Z, Yu H, Hu F, Liu J, Tang X, Li F. Fan Q, et al. Among authors: peng p. Nat Commun. 2022 Jul 9;13(1):3979. doi: 10.1038/s41467-022-31693-7. Nat Commun. 2022. PMID: 35810174 Free PMC article.
Efficacy and Safety of Lopinavir/Ritonavir or Arbidol in Adult Patients with Mild/Moderate COVID-19: An Exploratory Randomized Controlled Trial.
Li Y, Xie Z, Lin W, Cai W, Wen C, Guan Y, Mo X, Wang J, Wang Y, Peng P, Chen X, Hong W, Xiao G, Liu J, Zhang L, Hu F, Li F, Zhang F, Deng X, Li L. Li Y, et al. Among authors: peng p. Med. 2020 Dec 18;1(1):105-113.e4. doi: 10.1016/j.medj.2020.04.001. Epub 2020 May 19. Med. 2020. PMID: 32838353 Free PMC article. Clinical Trial.
Kinetics of SARS-CoV-2 specific IgM and IgG responses in COVID-19 patients.
Sun B, Feng Y, Mo X, Zheng P, Wang Q, Li P, Peng P, Liu X, Chen Z, Huang H, Zhang F, Luo W, Niu X, Hu P, Wang L, Peng H, Huang Z, Feng L, Li F, Zhang F, Li F, Zhong N, Chen L. Sun B, et al. Among authors: peng h, peng p. Emerg Microbes Infect. 2020 Dec;9(1):940-948. doi: 10.1080/22221751.2020.1762515. Emerg Microbes Infect. 2020. PMID: 32357808 Free PMC article.
Efficacy and Safety of Washed Microbiota Transplantation to Treat Patients with Mild-to-Severe COVID-19 and Suspected of Having Gut Microbiota Dysbiosis: Study Protocol for a Randomized Controlled Trial.
Wu LH, Ye ZN, Peng P, Xie WR, Xu JT, Zhang XY, Xia HH, He XX. Wu LH, et al. Among authors: peng p. Curr Med Sci. 2021 Dec;41(6):1087-1095. doi: 10.1007/s11596-021-2475-2. Epub 2021 Nov 30. Curr Med Sci. 2021. PMID: 34846698 Free PMC article. Clinical Trial.
Celebrex Adjuvant Therapy on Coronavirus Disease 2019: An Experimental Study.
Hong W, Chen Y, You K, Tan S, Wu F, Tao J, Chen X, Zhang J, Xiong Y, Yuan F, Yang Z, Chen T, Chen X, Peng P, Tai Q, Wang J, Zhang F, Li YX. Hong W, et al. Among authors: peng p. Front Pharmacol. 2020 Nov 6;11:561674. doi: 10.3389/fphar.2020.561674. eCollection 2020. Front Pharmacol. 2020. PMID: 33312125 Free PMC article.
2,264 results